According
to a new market report published by Transparency Market Research
(www.transparencymarketresearch.com) “E-Clinical Solution Software
Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2014 - 2020
Globally,
the e-clinical solution software market is witnessing significant
growth due to increasing clinical trials and R&D investments in
pharmaceuticals and life science. Increasing prevalence of diseases
supports clinical trials in different regions. Various lifestyle
associated diseases and genetic disorders in the Middle East and
North African countries have also enhanced clinical trials in the
respective regions. In addition, the pharmaceutical industry is
facing immense pressure to reduce the time consumed during clinical
trials and to raise the productivity of drugs. Presence of various
end users such as pharmaceuticals, clinical research organizations
(CRO) and healthcare providers has increased the acceptance of
e-clinical solution software. The global e-clinical solution software
market is estimated at USD 3,005 million in 2014. It is likely to
grow at a CAGR of 13.8% from 2014 to 2020 to reach USD 6,515.3
million in 2020.
Browse
Full E-Clinical Solution Software Market Research Report With
Complete TOC @
http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html
North
America is a traditional clinical trial region. The average cost of
pharmaceutical research and development for a successful drug
continues to increase from pre-clinical stage i.e. initial
development stage of drug till FDA approval i.e. drug is launched in
market. According to Oracle Corporation, an e-clinical software
company, the percentage share of global clinical trials conducted in
North America has reduced from 30% in 2006 to 19% in 2010. This was
due to regulatory and legal considerations, which shifted the
clinical trial market from North America to developing countries such
as India and China. This may lead to sluggish growth of clinical
trials in the region.
In
Europe, Countries in Central and Eastern Europe provide abundant
opportunities to life science companies for clinical development.
According to Oracle Corporation, the percentage of clinical trials
conducted in Western Europe has decreased from 25% to 19% and in
Eastern Europe, the percentage has increased from 10% to 13% during
2006-2010. Similarly, according to the U.S. National Institutes of
Health (Clinical Trial government registry), the clinical trials
conducted in Europe were 46,192 in May 2014.
Browse
Full Press release :
http://www.transparencymarketresearch.com/pressrelease/e-clinical-solution-software-market.htm
However,
Asia has become one of the fastest-growing markets for pharmaceutical
products. Improved industry regulatory laws and patent expiration
laws in various countries including Japan, China and India, have led
to the expansion of the clinical trials market in Asia. Asia has
lower cost of conducting clinical trials compared to Europe or the
U.S.
Oracle
Corporation, Medidata Solutions, PAREXEL International Corporation,
BioClinica, OmniComm Systems and others are the major players of
e-clinical solution software market.
The
e-clinical solution software market is segmented as follows:
E-Clinical
Solution Software Market, By Mode of Delivery
Web
based e-clinical solution software
Licensed
Enterprise e-clinical solution software
Cloud
based e-clinical solution software
E-Clinical
Solution Software Market, By Products
Clinical
Data Management
Clinical
Trial Management System
Electronic
Clinical Outcome Assessment Solution
Randomization
and Trial Supply Management
Safety
Solution
E-Clinical
Solution Software Market, By End Users
Pharmaceutical
Clinical
Research Organizations
Healthcare
Providers
E-Clinical
Solution Software Market, by Geography
North
America
U.S.
Europe
Germany
France
U.K.
Italy
Spain
Poland
Russia
Asia
China
South
Korea
Taiwan
India
Rest
of the World (Row)
Request
a Brochure of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2548
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants, use
proprietary data sources and various tools and techniques to gather,
and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Mr.Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com/
No comments:
Post a Comment